Alerts

The National Labor Relations Board (NLRB) may be on the cusp of a policy realignment.

On July 19, a major part of the European Union’s (EU) Ecodesign for Sustainable Products Regulation (ESPR) went into effect, and large companies can no longer destroy unsold clothing, accessories, or footwear.

Infrastructure disputes increasingly turn on a threshold question that many project sponsors assume has already been resolved: Does the governmental actor supporting, permitting, funding, or constructing the project actually possess legal authority to do so?

In a non-precedential opinion in Christopher M. Warman v. Local Yokels Fudge, LLC, the US Court of Appeals for the Third Circuit affirmed the district court’s judgment, upholding the denial of the defendants’ renewed motion for judgment as a matter of law on the trade secret claims under the Defend Trade Secrets Act (DTSA) and the Pennsylvania Uniform Trade Secrets Act (PUTSA).

Headlines that Matter for Companies and Executives in Regulated Industries

Tariffs and supply-chain pressures remain a constant operational reality for fashion brands and retailers.

On August 6, the US Food and Drug Administration (FDA) announced it is extending an existing Drug Supply Chain Security Act (DSCSA) exemption for small dispensers until November 27, 2027, as the FDA begins its small dispenser assessment.

At the midpoint of 2026, the agriculture industry is navigating a complex and ever-changing legal landscape shaped by the evolution of artificial intelligence (AI), trade and capital-market uncertainty, regulatory reform, and other policy issues.

On July 22, the US Securities and Exchange Commission (SEC) approved Nasdaq’s proposed rule requiring all Nasdaq-listed companies to maintain a minimum Market Value of Listed Securities (MVLS) of at least $5 million. Companies falling below this threshold for 30 consecutive business days would face immediate suspension and delisting.

Fashion trademark disputes often turn on a deceptively simple question: when does a design feature stop being decoration and start functioning as a brand identifier?

A lawsuit against sneaker brand On asks how much national pride a label can sell before it crosses the line into deception.

On June 17, the Council of the European Union (EU) and the European Parliament formally adopted the long-debated regulation for plants developed using certain new genomic techniques (NGTs).

Can your association board and senior leadership team answer these seemingly straightforward questions: “Where are our most important contracts, and is someone tracking what they require?” For many associations, the honest answer is that contract management happens in pieces across departments, in response to questions, and without dedicated trade association legal counsel weighing in until a problem surfaces.

Earlier this year we flagged New York’s “synthetic performer” disclosure law, N.Y. General Business Law § 396-b, the Synthetic Performer Law, as one to watch. The watch is over.

On July 14, the US Food and Drug Administration (FDA) announced final guidance regarding clinical investigations of psychedelic drugs.

Prop 65 Counsel: What To Know

Headlines that Matter for Companies and Executives in Regulated Industries

A recent California Superior Court decision against Kars4Kids, the charity known for its memorable advertising jingle, demonstrates the significant risks that charities can face if their solicitations are found to be misleading.

The Pharmacy Compounding Advisory Committee (PCAC) is a 14-member US Food and Drug Administration (FDA) advisory panel of pharmacists, physicians, and other experts. It reviews the scientific and safety record for bulk drug substances nominated for compounding and votes on non-binding recommendations to the FDA.

The US Department of Justice (DOJ) is increasingly using the False Claims Act (FCA) to pursue customs fraud, tariff evasion, and duty underpayments, resulting in significant settlements and expanded enforcement activity.

On June 26, Illinois Governor JB Pritzker signed House Bill 4517 into law, amending the Illinois Authorized Electronic Monitoring in Long-Term Care Facilities Act.

On July 13, the US Food and Drug Administration (FDA) proposed a new rule that would fundamentally change how certain drug manufacturers register their facilities and list their products with the agency.

California family offices with clients at or near the $1 billion net worth threshold should be monitoring Proposition 40, the 2026 Billionaire Tax Act, which has qualified for the November 3 ballot and could impose a one-time tax of up to 5% on the net worth of certain California residents if approved by voters.

In Wilbur-Ellis Company v. Gompert, the US Court of Appeals for the Eighth Circuit affirmed summary judgment for defendants, four former employees of plaintiff, who brought claims against them under the Defend Trade Secrets Act (DTSA) and the Nebraska Trade Secrets Act (NTSA). The Eighth Circuit affirmed the district court’s decision holding that the plaintiff employer had failed to identify its alleged secrets with specificity and had failed to connect circumstantial evidence to any particular trade secret or improper use.

Welcome to the July 2026 issue of “As the (Customs and Trade) World Turns,” our monthly newsletter where we compile essential updates from the customs and trade world over the past month. We bring you the most recent and significant insights in an accessible format, concluding with our main takeaways — aka “And the Fox Says…” — on what you need to know.